Seeking Alpha

Shares of Oxygen Biotherapeutics (OXBT +10.9%) extend yesterday's 2.6% closing gain after the...

Shares of Oxygen Biotherapeutics (OXBT +10.9%) extend yesterday's 2.6% closing gain after the company announced on yesterday that it's completed FDA requested studies on its Oxycyte, a treatment for traumatic brain injury and other brain conditions. The company says the results were positive overall, but it will continue to conduct more studies on the treatment.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs